LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy
Clinical trial NCT04081259 · COMPLETED
Trial details
- NCT number
- NCT04081259
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-15
- Primary completion
- 2023-08-03
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.